Matthias Bräutigam

3.8k total citations
95 papers, 2.6k citations indexed

About

Matthias Bräutigam is a scholar working on Dermatology, Immunology and Allergy and Epidemiology. According to data from OpenAlex, Matthias Bräutigam has authored 95 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Dermatology, 29 papers in Immunology and Allergy and 14 papers in Epidemiology. Recurrent topics in Matthias Bräutigam's work include Dermatology and Skin Diseases (35 papers), Allergic Rhinitis and Sensitization (23 papers) and Contact Dermatitis and Allergies (16 papers). Matthias Bräutigam is often cited by papers focused on Dermatology and Skin Diseases (35 papers), Allergic Rhinitis and Sensitization (23 papers) and Contact Dermatitis and Allergies (16 papers). Matthias Bräutigam collaborates with scholars based in Germany, Switzerland and Japan. Matthias Bräutigam's co-authors include Gottfried Weidinger, Regina Fölster‐Holst, Siegfried Nolting, Jens‐Michael Jensen, Ehrhardt Proksch, R.E. Schopf, Michael J. Meurer, Torsten Zuberbier, Thomas Schwarz and Stephan Pfeiffer and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Neurochemistry and Journal of Investigative Dermatology.

In The Last Decade

Matthias Bräutigam

93 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Bräutigam Germany 32 1.3k 884 659 409 382 95 2.6k
T. Ruzicka Germany 21 1.0k 0.8× 537 0.6× 262 0.4× 125 0.3× 354 0.9× 60 2.0k
Franz J. Legat Austria 26 942 0.7× 254 0.3× 282 0.4× 117 0.3× 242 0.6× 71 1.5k
David Rosmarin United States 21 920 0.7× 279 0.3× 153 0.2× 540 1.3× 443 1.2× 115 2.0k
Ove Bäck Sweden 20 597 0.4× 373 0.4× 409 0.6× 102 0.2× 125 0.3× 59 1.4k
Tatsuya Horikawa Japan 28 820 0.6× 561 0.6× 101 0.2× 341 0.8× 298 0.8× 78 2.5k
Joseph Tauber United States 28 672 0.5× 741 0.8× 165 0.3× 60 0.1× 427 1.1× 65 3.8k
Kiichiro Danno Japan 23 740 0.6× 152 0.2× 262 0.4× 173 0.4× 218 0.6× 100 1.7k
Mariko Seishima Japan 29 725 0.5× 132 0.1× 1.0k 1.6× 244 0.6× 845 2.2× 175 3.1k
Yutaka Hatano Japan 20 1.3k 0.9× 765 0.9× 107 0.2× 73 0.2× 340 0.9× 90 2.0k
Saeko Nakajima Japan 28 1.9k 1.4× 1.2k 1.3× 148 0.2× 101 0.2× 423 1.1× 80 3.3k

Countries citing papers authored by Matthias Bräutigam

Since Specialization
Citations

This map shows the geographic impact of Matthias Bräutigam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Bräutigam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Bräutigam more than expected).

Fields of papers citing papers by Matthias Bräutigam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Bräutigam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Bräutigam. The network helps show where Matthias Bräutigam may publish in the future.

Co-authorship network of co-authors of Matthias Bräutigam

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Bräutigam. A scholar is included among the top collaborators of Matthias Bräutigam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Bräutigam. Matthias Bräutigam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hajjar, Joud, Bettzy Stephen, Serdar A. Gurses, et al.. (2025). Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors. ESMO Open. 10(8). 105518–105518. 1 indexed citations
2.
Staubach, Petra, Martin Metz, Nadine Chapman‐Rothe, et al.. (2017). Omalizumab rapidly improves angioedema‐related quality of life in adult patients with chronic spontaneous urticaria: X‐ACT study data. Allergy. 73(3). 576–584. 44 indexed citations
3.
Staubach, Petra, Martin Metz, Nadine Chapman‐Rothe, et al.. (2016). Effect of omalizumab on angioedema in H 1 ‐antihistamine‐resistant chronic spontaneous urticaria patients: results from X‐ ACT , a randomized controlled trial. Allergy. 71(8). 1135–1144. 87 indexed citations
4.
Rutsch, Wolfgang, Bruno Scheller, Matthias Bräutigam, et al.. (2012). Intracoronary local paclitaxel delivery by X-ray contrast media for in-stent restenosis: a clinical pilot study to assess safety and tolerability.. PubMed. 60(4). 415–23. 1 indexed citations
5.
Pfaar, Oliver, Zoë Urry, Douglas S. Robinson, et al.. (2011). A randomized placebo‐controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy*. Allergy. 67(2). 272–279. 51 indexed citations
6.
Jensen, Jens‐Michael, Andreas Scherer, C. A. Wanke, et al.. (2011). Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis. Allergy. 67(3). 413–423. 60 indexed citations
7.
Proksch, Ehrhardt, et al.. (2009). Role of the epidermal barrier in atopic dermatitis. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 7(10). 899–910. 65 indexed citations
8.
9.
Aschoff, Roland, Uta Schwanebeck, Matthias Bräutigam, & Michael J. Meurer. (2008). Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild‐to‐moderate atopic dermatitis. Experimental Dermatology. 18(1). 24–29. 27 indexed citations
10.
Schwarz, Thomas, I. Kreiselmaier, Thomas Bieber, et al.. (2008). A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis. Journal of the American Academy of Dermatology. 59(1). 34–40. 25 indexed citations
11.
Kreuter, Alexander, Anna Sommer, Julia Hyun, et al.. (2006). 1% Pimecrolimus, 0.005% Calcipotriol, and 0.1% Betamethasone in the Treatment of Intertriginous Psoriasis. Archives of Dermatology. 142(9). 1138–43. 58 indexed citations
12.
Geßner, Christian, et al.. (2003). Miflonide®/Foradil® via Aerolizer® im Vergleich zu anderen antiinflammatorischen und antiobstruktiven Therapieregimes. Pneumologie. 57(3). 137–143. 8 indexed citations
13.
Takahashi, Masaya, Kosuke Aritake, Hajime Ito, et al.. (1999). Post‐stroke treatment with imidapril reduces learning deficits with less formation of brain oedema in a stroke‐prone substrain of spontaneously hypertensive rats. Fundamental and Clinical Pharmacology. 13(4). 475–483. 5 indexed citations
14.
Bräutigam, Matthias. (1998). Terbinafine versus itraconazole: A controlled clinical comparison in onychomycosis of the toenails. Journal of the American Academy of Dermatology. 38(5). S53–S56. 29 indexed citations
15.
Schopf, R. E., Thomas Hultsch, Johannes Lotz, & Matthias Bräutigam. (1998). Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin‐A. Journal of the European Academy of Dermatology and Venereology. 11(3). 234–239. 16 indexed citations
16.
Tausch, I, Matthias Bräutigam, Gottfried Weidinger, & Terry C. Jones. (1997). Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.. PubMed. 136(5). 737–42. 46 indexed citations
17.
Langenfeld, Matthias, et al.. (1996). Antihypertensive efficacy and orthostatic tolerance of bunazosin vs nitrendipine: a multicentre double-blind randomized controlled study.. PubMed. 10(12). 831–6. 3 indexed citations
18.
Jung, E. G., et al.. (1994). Systemic treatment of skin candidosis: a randomized comparison of terbinafine and ketoconazole. Mycoses. 37(9-10). 361–365. 16 indexed citations
19.
Bräutigam, Matthias, et al.. (1992). Effects of Calcipotriol (MC 903) and Calcitriol after Topical Application on the Skin of Hairless Rats. Skin Pharmacology and Physiology. 5(2). 87–92. 6 indexed citations
20.
Bräutigam, Matthias, et al.. (1987). Inducer T cell subpopulations in inflammatory dermatoses and in normal skin. Journal of Investigative Dermatology. 89(3). 322. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Ruzicka Breakdown of academic impact, for papers by Franz J. Legat Breakdown of academic impact, for papers by David Rosmarin Breakdown of academic impact, for papers by Ove Bäck Breakdown of academic impact, for papers by Tatsuya Horikawa Breakdown of academic impact, for papers by Joseph Tauber Breakdown of academic impact, for papers by Kiichiro Danno Breakdown of academic impact, for papers by Mariko Seishima Breakdown of academic impact, for papers by Yutaka Hatano Breakdown of academic impact, for papers by Saeko Nakajima
Rankless by CCL
2026